Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction

被引:276
作者
Haorah, James [1 ]
Ramirez, Servio H.
Schall, Kathy
Smith, Daniel
Pandya, Rita
Persidsky, Yuri
机构
[1] Nebraska Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Dept Pathol Microbiol, Omaha, NE USA
关键词
blood-brain barrier; brain endothelial cell; matrix metalloproteinases; oxidative stress; protein tyrosine kinase; protein tyrosine phosphatase;
D O I
10.1111/j.1471-4159.2006.04393.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The blood-brain barrier (BBB) formed by brain microvascular endothelial cells (BMVEC) regulates the passage of molecules and leukocytes in and out of the brain. Oxidative stress is a major underlying cause of neurodegenerative and neuroinflammatory disorders and BBB injury associated with them. Using human BMVEC grown on porous membranes covered with basement membrane (BM) matrix (BBB models), we demonstrated that reactive oxygen species (ROS) augmented permeability and monocyte migration across BBB. ROS activated matrix metalloproteinases (MMP-1, -2, and -9) and decreased tissue inhibitors of MMPs (TIMP-1 and -2) in a protein tyrosine kinase (PTK)-dependent manner. Increase in MMPs and PTK activities paralleled degradation of BM protein and enhanced tyrosine phosphorylation of tight junction (TJ) protein. These effects and enhanced permeability/monocyte migration were prevented by inhibitors of MMPs, PTKs, or antioxidant suggesting that oxidative stress caused BBB injury via degradation of BM protein by activated MMPs and by PTK-mediated TJ protein phosphorylation. These findings point to new therapeutic interventions ameliorating BBB dysfunction in neurological disorders such as stroke or neuroinflammation.
引用
收藏
页码:566 / 576
页数:11
相关论文
共 66 条
[61]   Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells [J].
Valentin, F ;
Bueb, JL ;
Kieffer, P ;
Tschirhart, E ;
Atkinson, J .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (06) :661-667
[62]   NAD(P)H:: quinone oxidoreductase 1 expression in multiple sclerosis lesions [J].
van Horssen, Jack ;
Schreibelt, Gerty ;
Bo, Lars ;
Montagne, Lisette ;
Drukarch, Benjamin ;
van Muiswinkel, Freek L. ;
de Vries, Helga E. .
FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 (02) :311-317
[63]   Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration [J].
Vos, CMP ;
Gartner, S ;
Ransohoff, RM ;
McArthur, JC ;
Wahl, L ;
Sjulson, L ;
Hunter, E ;
Conant, K .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 109 (02) :221-227
[64]   Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes [J].
Wang, Sophia ;
Lee, Sun-Ryung ;
Guo, Shu-Zhen ;
Kim, Woo Jean ;
Montaner, Joan ;
Wang, Xiaoying ;
Lo, Eng H. .
STROKE, 2006, 37 (07) :1910-1912
[65]  
WHISLER RL, 1994, LYMPHOKINE CYTOK RES, V13, P399
[66]   Transient forebrain ischemia modulates signal transduction from extracellular matrix in gerbil hippocampus [J].
Zalewska, T ;
Ziemka-Nalecz, M ;
Sarnowska, A ;
Domanska-Janik, K .
BRAIN RESEARCH, 2003, 977 (01) :62-69